Highline Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-361,450
| Closed | -$99M | – | 38 |
|
|
2018
Q1 | $99M | Buy |
+361,450
| New | +$99M | 3.38% | 13 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 37 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 31 |
|
|
2016
Q3 | – | Sell |
-303,874
| Closed | -$73.5M | – | 31 |
|
|
2016
Q2 | $73.5M | Buy |
303,874
+45,200
| +17% | +$10.9M | 2.8% | 16 |
|
|
2016
Q1 | $67.3M | Buy |
258,674
+146,174
| +130% | +$38.1M | 2.85% | 16 |
|
|
2015
Q4 | $34.5M | Buy |
+112,500
| New | +$34.5M | 1.63% | 21 |
|
|
2015
Q2 | – | Sell |
-157,200
| Closed | -$66.4M | – | 35 |
|
|
2015
Q1 | $66.4M | Buy |
+157,200
| New | +$66.4M | 3.02% | 13 |
|